Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$2.84 - $8.57 $241,400 - $728,450
-85,000 Closed
0 $0
Q1 2022

May 16, 2022

BUY
$5.64 - $15.64 $197,400 - $547,400
35,000 Added 70.0%
85,000 $614,000
Q4 2021

Feb 16, 2022

BUY
$9.8 - $17.02 $490,000 - $851,000
50,000 New
50,000 $819,000

Others Institutions Holding PRDS

About PARDES BIOSCIENCES, INC.


  • Ticker PRDS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,320,900
  • Description
  • Pardes Biosciences, Inc., a clinical stage biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics to improve the lives of patients suffering from life-threatening disease. Its lead candidate is the PBI-0451 that is in clinical development stage to treat and prevent severe acute respiratory syndrome ...
More about PRDS
Track This Portfolio

Track Ghost Tree Capital, LLC Portfolio

Follow Ghost Tree Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ghost Tree Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ghost Tree Capital, LLC with notifications on news.